UNAIDS Welcomes U.S. Approval of Drug to Stop HIV
July 18, 2012
UNAIDS on Tuesday hailed the US Food and Drug Administration's decision to approve Truvada to prevent HIV infection. The pill, which combines emtricitabine and tenofovir disoproxil fumarate, already is in use as an HIV treatment. UNAIDS noted that the new approval allows its use "to prevent the sexual transmission of HIV for people who do not have HIV, but who are at high risk of being exposed to the virus." FDA approved Truvada's use for pre-exposure prophylaxis as part of a broader HIV prevention strategy that includes condom use and other safer sex practices, risk-reduction counseling, and control of other STDs.
Agence France Presse
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)